FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385101003: Ointment (basic dose form)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479363017 Ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3534592017 Ointment (basic dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ointment Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Ointment Is a Basic dose form with semi-solid state of matter true Inferred relationship Existential restriction modifier
Ointment Has state of matter Semi-solid true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dovonex 50micrograms/g ointment (DE Pharmaceuticals) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (DE Pharmaceuticals) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betnovate 0.1% ointment (DE Pharmaceuticals) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dovobet ointment (DE Pharmaceuticals) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betnovate 0.1% ointment (DE Pharmaceuticals) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betnovate 0.1% ointment (DE Pharmaceuticals) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dovonex 50micrograms/g ointment (DE Pharmaceuticals) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Medihealth (Northern) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
White soft paraffin 50% / Liquid paraffin 50% ointment (Medihealth (Northern) Ltd) 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Medihealth (Northern) Ltd) 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
White soft paraffin 50% / Liquid paraffin 50% ointment (Medihealth (Northern) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dalbecal 50micrograms/g / 0.5mg/g ointment (Teva UK Ltd) 60 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% ointment (Medihealth (Northern) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dalbecal 50micrograms/g / 0.5mg/g ointment (Teva UK Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Medihealth (Northern) Ltd) 60 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% ointment (Medihealth (Northern) Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Medihealth (Northern) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dalbecal 50micrograms/g / 0.5mg/g ointment (Teva UK Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Medihealth (Northern) Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dalbecal 50micrograms/g / 0.5mg/g ointment (Teva UK Ltd) 120 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% ointment (Medihealth (Northern) Ltd) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Sunscreen lip balm Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Uvistat lipscreen SPF 30 (LPC Medical (UK) Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Sunscreen lip balm 5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Uvistat lipscreen SPF 30 (LPC Medical (UK) Ltd) 5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 2.5% eye ointment (UniChem Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 2.5% eye ointment (UniChem Ltd) 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd) 120 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Uvistat lipscreen SPF 50 (Dendron Brands Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Uvistat lipscreen SPF 50 (Dendron Brands Ltd) 5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (UniChem Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (UniChem Ltd) 120 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Brochlor 1% eye ointment (sanofi-aventis) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Brochlor 1% eye ointment (sanofi-aventis) 4 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (A A H Pharmaceuticals Ltd) 120 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.6% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Haemorrhoid Relief ointment (The Boots Company Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Optrex Infected Eyes 1% eye ointment (Reckitt Benckiser Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.6% ointment 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Haemorrhoid Relief ointment (The Boots Company Plc) 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Optrex Infected Eyes 1% eye ointment (Reckitt Benckiser Plc) 4 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Boots Vapour Chest Rub (The Boots Company Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Boots Vapour Chest Rub (The Boots Company Plc) 45 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dulcamara / Lysimachia nummularia ointment 100 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dexpanthenol 5% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Bepanthen Nappy Care 5% ointment (Bayer Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dexpanthenol 5% ointment 100 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dexpanthenol 5% ointment 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Bepanthen Nappy Care 5% ointment (Bayer Plc) 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Bepanthen Nappy Care 5% ointment (Bayer Plc) 100 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Mentholatum Vapour Rub Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Mentholatum Vapour Rub (The Mentholatum Company Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Mentholatum Vapour Rub 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Mentholatum Vapour Rub 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Mentholatum Vapour Rub (The Mentholatum Company Ltd) 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Mentholatum Vapour Rub (The Mentholatum Company Ltd) 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Methyl salicylate ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Emulsifying ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrous ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrous wool fat BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Simple ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Wool alcohols ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc 15% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc+castor oil ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 3 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Ichthammol 10% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Salicylic acid 2% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Sulfur+salicylic acid ointment BPC Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier

Start Previous Page 6 of 64 Next End


This concept is not in any reference sets

Back to Start